Eppen_TracePCR_Dec24
  Editorial
 HEAVENS WILL NOT FALL   
 Wednesday, December 31, 2025 
 For the pharmaceutical companies with a turnover of less than Rs. 250 crore, time is ticking away fast to implement the Revised Schedule M. According to reports, a large number of MSME units, especially small and 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Valneva and Serum Institute of India discontinue chikungunya vaccine license agreement
17:00  [IST]Union health minister releases 10th edition of Indian Pharmacopoeia 2026
16:00  [IST]Mabwell's adalimumab biosimilar receives Indonesian FDA marketing approval
15:00  [IST]US FDA approves Vanda Pharma’s Nereus, an oral NK-1 receptor antagonist for prevention of vomiting induced by motion
14:00  [IST]Biologics X 3DCC Conference 2026 will be held on January 22 & 23, 2026 in Goa, India
13:45  [IST]New leadership elected for Telangana State Chemists and Druggists Association
more news >>
TOP NEWS
08:00  [IST]DoP includes member of HTAIn in expert committee on pricing of drugs
08:00  [IST]Proposed VBSA Bill to mandate radical transparency for pharmacy education
08:00  [IST]BDCDA calls on retailers & wholesalers to uphold ethical trade, steer clear of illegal practices
08:00  [IST]Pharma industry, exporters to discuss PLI scheme for APIs with Korea to attract investment in 2026
08:00  [IST]Year 2026 marks inflection point for pharma & medtech sectors as cos go for non-invasive drug delivery solutions
08:00  [IST]Almost 85% of overcharged amount claimed by NPPA yet to be recovered
more news >>
YESTERDAY'S NEWS
18:00  [IST]Ultragenyx Pharma announces phase 3 Orbit & Cosmic results for setrusumab in osteogenesis imperfecta
17:00  [IST]Enveric Biosciences receives US patent entitled, “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives”
16:00  [IST]Establishment Labs Holdings submits Motiva implants to US FDA for approval in primary and revision breast reconstruction
15:00  [IST]WORK Medical’s subsidiary Hunan Saitumofei receives manufacturing approval for its Class II medical devices
11:15  [IST]Ministry of health issues draft amendment to remove cough syrups from Schedule K
10:45  [IST]Health ministry bans nimesulide formulations above 100 mg for human use
more news >>
INTERVIEW  
Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Avians_2025
                                                         
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram